Using advanced CT imaging to assess patients with acute hemorrhagic stroke
Multimodal Computed Tomography in Patients With Acute Hemorrhagic Stroke (MCTAHS)
This study is testing how different types of CT scans can help doctors understand and improve outcomes for patients who have had an acute hemorrhagic stroke.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT06061185 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect data on patients with acute hemorrhagic stroke to evaluate the prognostic value of multimodal computed tomography (CT). Participants will undergo three types of CT scans: non-contrast CT, CT angiography, and CT perfusion. The study will follow approximately 10,000 patients for at least one year after discharge to assess various neurological outcomes and complications. The goal is to better understand the pathophysiological changes and improve intervention strategies for these patients.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 85 who are experiencing an acute hemorrhagic stroke.
Not a fit: Patients with a history of previous strokes, serious comorbidities, or those who have received prior treatments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of acute hemorrhagic stroke and improve patient outcomes through better prognostic assessments.
How similar studies have performed: Other studies utilizing multimodal CT imaging have shown promise in improving outcomes for stroke patients, indicating a potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. age ≥ 18, ≤ 85 years; 2. presence with hemorrhagic stroke Exclusion Criteria: 1. with a history of previous history of ischemic/hemorrhagic stroke; 2. admission to the emergency department more than a week after symptom onset; 3. serious medical history or existing comorbidities; 4. physical disability due to previous diseases; 5. prior treatment such as external ventricular drainage, digital subtraction angiography and lumbar puncture in other institution; 6. poor original image quality; 7. incomplete follow-up.
Where this trial is running
Beijing, Beijing Municipality
- Beijing Tiantan Hospital — Beijing, Beijing Municipality, China (Recruiting)
Study contacts
- Study coordinator: Xiaolin Chen, M.D.
- Email: chenxiaolin@bjtth.org
- Phone: 13810624845
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.